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Control of basal extracellular adenosine concentration
in rat cerebellum
Mark J. Wall, Alison Atterbury and Nicholas Dale
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To re-examine how the basal extracellular concentration of adenosine is regulated in acutely
isolated cerebellar slices we have combined electrophysiological and microelectrode biosensor
measurements. In almost all cases, synaptic transmission was tonically inhibited by adenosine
actingviaA1 receptors.Bycontrast,inmostslices,thebiosensorsdidnotmeasureanadenosine
tone but did record a spatially non-uniform extracellular tone of the downstream metabolites
(inosineandhypoxanthine).Mostoftheextracellularhypoxanthinearosefromthemetabolism
of inosine by ecto-purine nucleoside phosphorylase (PNP). Adenosine kinase was the major
determinant of adenosine levels, as its inhibition increased both adenosine concentration and
A1 receptor-mediated synaptic inhibition. Breakdown of adenosine by adenosine deaminase
was the major source of the inosine/hypoxanthine tone. However adenosine deaminase played
a minor role in determining the level of adenosine at synapses, suggesting a distal location.
Blockade of adenosine transport (by NBTI/dipyridamole) had inconsistent effects on basal
levelsofadenosineandsynaptictransmission.Unexpectedly,applicationofNBTI/dipyridamole
prevented the efﬂux of adenosine resulting from block of adenosine kinase at only a
subset of synapses. We conclude that there is spatial variation in the functional expression
of NBTI/dipyridamole-sensitive transporters. The increased spatial and temporal resolution of
thepurinebiosensormeasurementshasrevealedthecomplexityofthecontrolofadenosineand
purine tone in the cerebellum.
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The purine adenosine is an important neuromodulator,
with both excitatory and inhibitory actions within the
CNS.Thispurinemoleculeisinvolvedindiverseprocesses
includinglocomotion,sleepandrespiration,andprovides
neuroprotection during hypoxia/ischaemia. Although the
basal extracellular levels of adenosine in the brain are low
(Newman & McIlwain, 1977; Dunwiddie & Diao, 1994),
there is still sufﬁcient to tonically activate high-afﬁnity
A1 receptorsandproducesynapticinhibition(Dunwiddie
& Diao, 1994; Takahashi et al. 1995; Dittman & Regehr,
1996). Regulation of the extracellular level of adenosine
in the brain is crucial, since small changes in adenosine
levelswillaffectthedegreeofsynapticinhibition,andthus
modulate neural processing.
The extracellular concentration of adenosine will be
determinedbythebalanceofproductionandelimination.
In many cases, the source and mechanism of adenosine
release are unclear but could occur via ATP metabolism
(releasedbyexocytosis,Edwardsetal.1992;Jo&Schlichter,
1999, or released through gap junction hemi-channels,
Arcuino et al. 2002; Stout et al. 2002; Pearson et al. 2005),
transportfromthecellcytoplasm(Craig&White,1993;Gu
et al. 1995; Sweeney, 1996) or possibly by the exocytosis
of adenosine itself (Wall & Dale, 2007). The actions of
adenosineareterminatedbyacombinationofmetabolism
to inosine (by the enzyme adenosine deaminase) and by
translocation into neurons or glia by either equilibrative
transporters such as ENT1 and ENT2 or concentrative
transporters (for review see Noji etal.2004;Baldwin etal.
2004).
Onceinternalised,adenosinecanbephosphorylated(by
adenosine kinase) to form AMP, thus maintaining low
levels of intracellular adenosine (for review see Boison,
2006). Because the levels of adenosine are determined
by a complex interplay of enzymes and transporters,
several studies have investigated the components
that contribute to determining extracellular adenosine
concentration.Inmanystudiesblockingadenosinekinase
has a major effect on adenosine concentration, whereas
blockadeofadenosinedeaminasehasamuchsmallereffect
(Zhang et al. 1993; Pak et al. 1994; Lloyd & Fredholm,
1995).
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The aim of this study is two-fold: ﬁrstly to investigate
whether recently developed biosensors can be used to
determine what controls the basal levels of adenosine in
brain slices. Biosensors have inherently better spatial and
temporal resolution than other methods such as HPLC
or microdialysis, for measuring purine levels. Biosensors
have been successfully used to investigate increases in
adenosine during episodes of ischaemia, hypoxia and
hypercapnia (Dale et al. 2000; Frenguelli et al. 2003,
2007; Dulla et al. 2005) and have been used to measure
adenosine release following electrical stimulation (Wall
& Dale, 2007). However, measurement of the basal tone
of adenosine is more challenging as the concentration
of adenosine will be low and may be more difﬁcult to
detect against a non-uniform background of downstream
adenosine metabolites.
The second aim is to investigate adenosine levels in
the cerebellum, since relatively little is known about
how the extracellular concentration of adenosine is
controlled in this part of the brain. There is growing
evidence that adenosine plays an important role in the
processingofinformationbycerebellarcircuits.Adenosine
is concentrated in the soma and dendrites of cerebellar
Purkinje cells (Braas et al. 1986), and adenosine A1
receptors are expressed within the cerebellum (Rivkees
etal.1995).ThetonicactivationofA1receptors,producing
synaptic inhibition, provides indirect evidence that an
extracellular tone of adenosine is present in cerebellar
slices (Takahashi et al. 1995; Dittman & Regehr, 1996).
Thesourceofthisextracellularadenosineisunclear,butin
recent studies, Wall & Dale (2007) have directly measured
adenosinereleaseinthecerebellumandBeierlein&Regehr
(2006)havereportedthereleaseofATPfromparallelﬁbres.
The enzymes required for purine metabolism are present
in the cerebellum: ecto-ATPase (CD39, Wang & Guidotti,
1998), 5 nucleotidase (Schoen et al. 1987) and adenosine
deaminase(Geiger&Nagy,1986).Nucleosidetransporters
are also expressed in the cerebellum (Anderson et al.
1999a,b). However, the relative importance of adenosine
transport, phosphorylation (by adenosine kinase) and
metabolism (by adenosine deaminase) in the regulation
of the adenosine tone remains uncertain. Studies of
synapticmembranes,culturedgliaandhomogenisedbrain
tissue suggest that adenosine deaminase activity in the
cerebellum is comparable to or higher than in other brain
regions (Yamada et al. 1998; Wink et al. 2003; Kukulski
et al. 2004). However the physiological relevance of data
from such studies is unclear.
Methods
Preparation of cerebellar slices
Parasagittal or transverse slices of cerebellar vermis
(400μm) were prepared from male Wistar rats, at post-
natal days 21–28 (P21–28). As described previously (Wall
&Usowicz,1997)andinaccordancewiththeUKAnimals
(Scientiﬁc Procedures) Act 1986, male rats were killed by
cervical dislocation and decapitated. The cerebellum was
rapidlyremovedandsliceswerecutonaMicromHM650V
microslicer in cold (2–4◦C) high Mg2+,l o wC a 2+ aCSF,
composedof(mm):127NaCl,1.9KCl,7MgCl2,0.5CaCl2,
1.2 KH2PO4, 26 NaHCO3,1 0d-glucose (pH 7.4 when
bubbled with 95% O2 and 5% CO2, 300mosmoll−1).
SliceswerestoredinnormalaCSF(1.3mmMgCl2,2.4mm
CaCl2) at room temperature for 1–6h before recording.
Extracellular recording
Anindividualslicewastransferredtoarecordingchamber,
submergedinaCSFandperfusedat6mlmin−1(30–35◦C).
Peristaltic pumps were used to pump aCSF in and out
of the recording chamber, thus ensuring a constant ﬂow
rate. The slice was placed upon a suspended grid to
allow perfusion of the slice from above and below and
thus reduce the likelihood of hypoxia. Furthermore, all
solutions were vigorously bubbled (95% O2/5% CO2)
and all tubing had low gas permeability (Tygon). For
the stimulation of parallel ﬁbres, square voltage pulses
(2–5V, 200μs duration) were delivered by an isolated
pulse stimulator (model2100 AM systems Everett WA,
USA) via a concentric bipolar metal stimulating electrode
(FHC) placed on the surface of the molecular layer in a
transverse slice. The recording electrode (an aCSF-ﬁlled
microelectrode)wasplacedonthesametrackalongwhich
the parallel ﬁbres travel (‘on-beam’ Yuan & Atchison,
1999).Atypicalextracellularﬁeldpotentialconsistedofan
initial component which persisted in either 10μm CNQX
or5mmkynurenatebutwasblockedby1μmTTX(parallel
ﬁbre volley) followed by a component which could be
block edby1μmTTXandgreatlyreducedbyeither10μm
CNQX or 5mm kynurenate. This component is probably
produced by parallel ﬁbre-mediated glutamatergic
excitatory synaptic currents and subsequent action
potentials in Purkinje cells and interneurons (Clark
& Barbour, 1997). Parallel ﬁbre (PF) EPSP amplitude
was estimated from the CNQX-/kynurenate-sensitive
potential, which was measured by subtracting what
remained in CNQX/kynurenate from control potentials.
Conﬁrmation of PF EPSP identity was achieved by
evoking pairs of EPSPs (interval 50ms) and observing
facilitation (Atluri & Regehr, 1996) and by examining
the pharmacological proﬁle (inhibition by A1, GABAB
and mGlu4R receptor agonists). Pairs of PF EPSPs were
evoked at 0.1Hz, and the amplitude of the ﬁrst EPSP was
used as a measure of adenosine A1 receptor activation.
The paired pulse ratio (EPSP2/EPSP1) was used to test for
a presynaptic action on release probability. Extracellular
recordings were made using an ISO-DAM extracellular
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ampliﬁer (WPI), ﬁltered at 1kHz and digitised online
(10kHz) with a Digidata 1322A (Axon Instruments)
controlled by 9.2 (Axon pCLAMP).
Purine biosensors
Sensors were obtained from Sarissa Biomedical Ltd
(Coventry UK). In brief, the adenosine sensor consisted
of three entrapped enzymes (adenosine deaminase, AD,
purine nucleoside phosphorylase, PNP and xanthine
oxidase, XO), within a matrix that was deposited around
a 25–50μm platinum or platinum/iridium (90/10) wire
(Llaudet et al. 2003). The biosensor had an exposed
length of ∼500μm that was screened with an inner
permselectivity layer to greatly reduce responses to
electro-active interferents (such as 5-HT, noradrenaline,
dopamineandascorbate).Itwasthencoatedwithenzymes
to make it capable of detecting purines. Five types of
purinebiosensorwereusedinthisstudytoidentifyreleased
substances. Firstly, a screened null sensor, possessing
the deposition matrix but no enzymes, was used to
control for the release of any non-speciﬁc electro-active
interferents.Secondly,screenedbiosensorscontainingjust
XO (only responsive to hypoxanthine, HYPO), PNP and
XO (responsive to inosine and hypoxanthine, INO) and
PNP,XOandAD(responsivetoinosine,hypoxanthineand
adenosine,ADO)wereused.Thedifferencesignalbetween
these three types of biosensors gave the speciﬁc hypo-
xanthine,inosineandadenosinesignals.Matchingthesizes
and sensitivities of the biosensor types as well as careful
positioning into or above the slice was vital to optimise
the differential recordings. The screened ATP biosensor
(Llaudet et al. 2005) consisted of the entrapped enzymes
glycerol kinase (GK) and glycerol-3-phosphate oxidase
(G3POx). Glycerol 2mm was included in solutions, as
glycerol is a co-substrate required for ATP detection. A
full description of the properties of the biosensors has
beenpublished.Theyshowalinearresponsetoincreasing
concentration of analyte, are fast to respond and have a
10–90% rise time of less than 10s (Llaudet et al. 2003,
2005).
Thebiosensorswereeithercarefullyinserted(atanangle
of ∼70deg) either into the molecular layer or positioned
just above the surface of the slice (either at an angle
of ∼70deg or bent so their longitudinal surface was
parallel to the slice surface). Biosensors were calibrated
withknownconcentrations(10μm)ofadenosine,inosine,
hypoxanthineandATP.Calibrationwasperformedbefore
the slice was present in the perfusion chamber and after
the slice had been removed; this allowed measurement of
any reduction in sensitivity during the experiment.
To quantify the concentrations of adenosine, inosine
andhypoxanthine,itwasassumedthattheconcentrations
of these purines were homogenous in the slice and
thus the calibrated signals can be subtracted from
one another. The HYPO sensor will only detect
hypoxanthine and thus this signal can be subtracted
from the signal on the INO sensor to give the inosine
signal. The signal from the INO sensor (comprising
inosine and hypoxanthine) can be subtracted from the
signal on the ADO sensor to give the speciﬁc adenosine
signal. For example, assuming identical sensitivity for
the ADO, INO and HYPO sensors and that 10μm
of each analyte (adenosine, inosine or hypoxanthine)
produces 3000pA. Clearly the ADO sensor will produce
a current of 3000pA in response to 10μm adenosine,
10μM inosine or 10μm hypoxanthine, whereas the
HYPO sensor will only respond to hypoxanthine. If
upon exposure to tissue, the HYPO sensor produces a
current of 300pA, then the hypoxanthine concentration
in the tissue is (300pA/3000pA×10μm)=1μm.I f
The INO sensor produces a current of 700pA, then
subtracting the current due to hypoxanthine (300pA)
leaves 400pA which is the current due to inosine
detection. Thus the inosine concentration in the tissue
is (400pA/3000pA×10μm)=1.3μm. The signal from
the INO sensor can then be subtracted (in a similar way)
fromtheADOsensortogivethespeciﬁcadenosinesignal.
In reality, because the sensitivity of sensors to inosine
and hypoxanthine will differ slightly, this has to be taken
intoaccountduringsubtractionbyappropriateweighting.
Notethatthisdifferentialsubtractionprocedureonlygives
validresultsifthemetabolitesaredistributedinauniform
identical manner. If this is not the case, for example there
areconcentration‘hotspots’,itwillbevirtuallyimpossible
to place the different sensors at identical relative locations
with respect to the hotspots. Hence the signals will not be
equivalent from the different sensors. Thus the detection
of a purine tone will be accurate but its subdivision into
concentrations of adenosine, inosine and hypoxanthine
may be less so. Sensor signals were acquired at 1kHz with
a Digidata1322A or a MiniDigi (Axon) using Pclamp9.2
or Axoscope9.2 (Axon). All values are mean ± SEM.
Drugs
All drugs were made up as 10–100mm stock solutions,
stored frozen and then thawed and diluted with aCSF
on the day of use. Iodotubercidin, pyridoxal phosphate-
6-azo(benzene-2,4-disulfonic acid) tetrasodium salt
(PPADs), suramin, Evans Blue, α,β-methylene-ADP,
adenosine, inosine, hypoxanthine, 6-[(4-nitrobenzyl)
thiol]-9-β-d-ribofuranosylpurine (NBTI) 8-cyclopentyl-
theophylline (8CPT) and dipyridamole were purchased
from Sigma. Erythro-9-(2-hydroxy-3-nonyl) adenine
(EHNA),6-cyano-7-nitroquinoxaline-2,3-dione(CNQX),
ARL67156 and d(−)-2-amino-5-phosphonopentanoic
acid (AP5) were purchased from Tocris-Cookson. ATP
was purchased from Roche.
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Figure 1. Endogenous adenosine inhibits parallel ﬁbre to
Purkinje cell synaptic transmission
A, average of 50 pairs (interval 50 ms) of parallel ﬁbre–Purkinje cell
(PF) EPSPs illustrating paired pulse facilitation (greater amplitude of
second EPSP compared to ﬁrst). PF EPSPs were averaged by aligning on
the stimulus artefact. B, the A1 receptor antagonist 8CPT (1 μM)
increased PF EPSP amplitude (31%) demonstrating tonic activation of
A1 receptors. PF EPSPs were blocked by CNQX (10 μM), conﬁrming
their production through glutamate receptor activation. Graph plots
the amplitude of individual PF EPSPs against time. C, The antagonist
8CPT (1 μM) decreased the paired pulse ratio, conﬁrming a presynaptic
site of action. Graph plots the paired pulse ratio against time for the
PF EPSPs in B. The line is the mean paired pulse ratio for ﬁve EPSPs.
D, adenosine (100 μM) reversibly decreased PF EPSP amplitude (48%).
Graph plots the amplitude of individual PF EPSPs against time.
E, adenosine produced a marked increase in the paired pulse ratio,
indicating a presynaptic site of action. Graph plots the paired pulse
ratio against time for the PF EPSPs in D. The line is the mean paired
pulse ratio for three EPSPs. F, graph summarising the actions of
purines on PF EPSP amplitude (n = 5–12).
Results
Parallel ﬁbre EPSPs are tonically inhibited by
adenosine in the majority of slices
Previous studies have shown that A1 adenosine receptors
on parallel ﬁbre–Purkinje cell synapses tonically inhibit
synaptic transmission, suggesting the presence of an
extracellular adenosine tone (Kocsis et al. 1984; Takahashi
et al. 1995; Dittman & Regehr, 1996). To conﬁrm the
presenceofextracellularadenosineinourcerebellarslices,
wehavestudiedparallelﬁbre–Purkinjecellexcitatorypost-
synaptic potentials (PF EPSPs). The identity of PF EPSPs
was conﬁrmed by the presence of paired pulse facilitation
(PPF, with a 50ms interval the paired pulse ratio was
1.3±0.01,n=20,Fig.1A)andthesensitivityofPFEPSPs
to the glutamate receptor antagonists CNQX (10μM) or
kynurenic acid (5mm, Fig.1B).
We conﬁrmed previous reports (Takahashi et al. 1995;
Dittman & Regehr, 1996) that inhibitory A1 receptors on
parallelﬁbre–Purkinjecellsynapsesaretonicallyactivated
inslices,asapplicationofA1receptorantagonistsenhanced
PF EPSP amplitude (1μm 8CPT or 200μM theophylline
46.1±8.6%increase)andsigniﬁcantlyreducedthepaired
pulse ratio (from 1.3±0.04 to 1.2±0.03, Fig.1B and
C) in 17 out of 19 slices. In two slices, the antagonists
had no effect on PF EPSP amplitude. The continual
activation of A1 receptors is probably a consequence of
the presence of endogenous adenosine, since application
of adenosine (100μm) reduced PF EPSP amplitude by
60.5±4.8% and increased the paired pulse ratio from
1.3±0.06 to 1.6±0.08, (n=12, Fig.1D and E). As
the applied adenosine could be metabolised to inosine
and hypoxanthine, the activity of these metabolites on
synaptic transmission was assessed. As expected, neither
inosine nor hypoxanthine (100μm) had any signiﬁcant
effect on either the PF EPSP amplitude or the paired
pulse ratio (n=5, Fig.1F). ATP (100μm) also reduced
EPSP amplitude (50±6.5%). Since this inhibition was
blocked by A1 receptor antagonists (n=6), ATP must be
metabolised to adenosine. Our results conﬁrm previous
reports that there is a tone of extracellular adenosine in
the cerebellum which inhibits synaptic transmission and
is present in the majority (∼90%) of slices.
Biosensors detect adenosine metabolites but not
adenosine in most cerebellar slices
We have used microelectrode biosensors to directly
measure the concentration of extracellular adenosine
present in cerebellar slices. The use of different sensors
allows the detection of ATP (a possible source of
adenosine), adenosine and the adenosine metabolites
(inosine and hypoxanthine). A null sensor was also
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present to control for any non-speciﬁc electro-active
interferents. To verify our ﬁndings we used two different
methods. Firstly, we measured the current produced
when purine biosensors were moved close to the slice
surface (Fig.2A). This method has the advantage that it is
non-invasive and thus any purines detected do not result
from biosensor-mediated tissue damage. Movement of
nullsensors(withnoenzymecascade,n=10)closetothe
slicesurfaceproducedeithernocurrentorasmallnegative
current; thus any electro-interferents released from the
slice are not detected by the biosensors. The signal on
ATP biosensors (n=10) was no different from that on
nullsensors(Fig.2A),andthusthelevelofATPattheslice
surface is below the limits of detection by the biosensors
(∼60nm).Incontrast,largecurrentsweremeasuredwhen
ADO,INOandHYPObiosensorsweremovedclosetothe
Figure 2. Adenosine metabolites, but not
adenosine, can be measured in the extracellular
space of cerebellar slices
A, example of biosensor traces from an experiment to
measure the concentration of purines at the slice
surface. Superimposed traces from ADO, INO, HYPO
and ATP sensors. After the biosensors were moved close
to the slice surface there was a rapid increase in the
baseline current of ∼300–500 pA on the ADO, INO and
HYPO sensors. Moving the ATP biosensor close to the
slice produced a small drop in the baseline current.
B, the traces from A were normalised by calibration and
subtracted to give the amounts of adenosine, inosine
and hypoxanthine detected at the slice surface (see
Methods). C, graph plots the mean concentration of
purines measured at the surface of 12 cerebellar slices.
Currents were scaled by sensor calibration and then
subtracted (as in B). D, examples of experiments where
biosensors were used to measure the purine
concentration within slices. Biosensors were carefully
pushed into slices, left in position for ∼30 min and then
withdrawn. The top panel shows the response following
removal of an ATP sensor from a slice. There is a small
sustained increase in current (similar to that observed on
null sensors) and thus no ATP was detected. In contrast
when an inosine (INO) sensor was removed there was a
sustained fall in current as a result of terminating purine
detection (bottom panel). The transient upward
deﬂections (arrows) are presumably due to cell damage
and the release and resultant metabolism of ATP.
E, graph plotting the mean concentration of purines
measured in the extracellular space of 16 cerebellar
slices. Currents were scaled by sensor calibration and
then subtracted (see Methods).
slice surface (Fig.2A). After calibration and subtraction
(Fig.2B), to determine the speciﬁc analyte concentration
(seeMethods),adenosinewasonlydetectedinasingleslice
(1 out of 12 slices at 1.5μm), whereas hypoxanthine was
detectedinallslices(0.8±0.2μm,12outof12slices)and
inosine was detected in 50% of slices (0.5±0.1μm,i n6
slices, Fig.2B).
The second method measured the extracellular
concentration of purines within the cerebellum, by
carefully inserting purine biosensors into the slice. After
30min biosensors were removed from the tissue and
the resultant deﬂection in baseline current was used as
a measure of purine concentration within the slice. If
extracellularpurinesarepresent,removalofthebiosensor
fromthesliceshouldresultinarapidfallinbaseline,asthe
purines will no longer be measured. This method avoids
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thedetectionofpurinereleaseduetotissuedamageduring
sensor insertion. Removal of null sensors produced either
nocurrentdeﬂectionorasmallpositivecurrentdeﬂection.
TheresponseofATPbiosensorswasnodifferentfromnull
sensors (32–34◦C n=20 slices, room temperature n=10
slices, Fig.2D), and thus no ATP tone could be detected
within the tissue. However clear falls in baseline current
were observed following the removal of ADO, INO and
HYPO biosensors from slices (n=6 slices, Fig.2D). After
calibration and subtraction, hypoxanthine was detected
in 81% of the slices (1.8±0.3μm, n=13 slices), inosine
was detected in 50% of the slices (2.5±1.1μm, n=8
slices) and adenosine was detected in only 12.5% of
the slices (1.2±0.5μm, n=2 slices Fig.2E). Thus both
methods of purine measurement gave similar results: no
ATP was detected, an adenosine tone was occasionally
Figure 3. Exogenous ATP is metabolised by cerebellar slices
A, example traces from adenosine (ADO), null, inosine (INO) and
hypoxanthine (HYPO) biosensors placed on the surface of a cerebellar
slice. Following application of 100 μM ATP, currents were produced on
all the sensors except the null. B, the traces from A, calibrated and
subtracted illustrating the metabolism of ATP to adenosine, inosine,
and hypoxanthine. C, graph plots the mean concentration of ATP
metabolites measured at the surface of slices (n = 6) and within slices
(n = 7) following application of 100 μM ATP.
presentandmostslicesexhibitedatoneforinosineandor
hypoxanthine.
The inability to reliably detect adenosine with the
biosensors contrasts with electrophysiological studies on
synaptic transmission that demonstrate an extracellular
adenosine tone in 90% of cases. Adenosine could be
metabolisedtoinosineandhypoxanthinebeforeitreaches
the sensors, and may thus be present only in the restricted
space around parallel ﬁbre synapses. However it is very
unlikely that the sensors will not sample from this
compartment,asthesynapsesarepresentatahighdensity
in the molecular layer.
A more likely explanation for this discrepancy is that
the subtraction procedure used to measure adenosine
is inaccurate. This could arise from a non-uniform
distribution of the analytes adenosine, inosine and
hypoxanthine, which would reduce the accuracy of the
subtraction procedure (see Methods) In many cases,
subtraction of the calibrated INO sensor signals implied a
negative concentration of adenosine (clearly impossible),
strongly indicating non-uniform concentrations of
inosine and hypoxanthine. Our data suggest considerable
variation in the levels of inosine (0–0.6μm) and
hypoxanthine (range 0.1–3μm) between slices. If this
reﬂects hotspots of release/production, depending on
enzyme location relative to sensor position, then the
differential measurement procedure will not give accurate
concentrations of adenosine and inosine.
Exogenous ATP and adenosine are metabolised
through to hypoxanthine
To test whether: (1) adenosine can be metabolised to
inosine and hypoxanthine (to give the observed purine
tone),(2)adenosinecanbedetectedincerebellarslices,and
(3) there are hotspots of extracellular purine metabolism,
exogenous ATP was applied to slices and the real-time
production of metabolites was measured using ADO,
INO and HYPO biosensors. As before, this experiment
was carried out in two ways: ﬁrstly non-invasively with
sensorsplacedclosetotheslicesurface,andsecondlywith
the biosensors placed within the slice. The inﬂow was
changed from control saline to 100μm ATP for 5min.
The exact duration of the ATP application is not known
(as the 5min includes the time taken for the ATP to
reach the bath and exchange with the bath solution).
However,becausetheﬂowrateisconstant,theapplications
will be reproducible. Application of ATP rapidly resulted
in the detection of 3.8±1μm adenosine, 0.3±0.2μm
inosine and 0.14±0.03μm hypoxanthine at the slice
surface (n=6, Fig. 3). Similar results were found when
the biosensors were placed within the slice (2.5±0.6μm
adenosine, 0.5±0.3μm inosine and 0.3±0.1μm hypo-
xanthine, n=7, Fig.3C). In all slices, after subtraction,
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there was a positive amount of adenosine demonstrating
that the subtraction procedure was successful. This
conﬁrmsthatbiosensorscanbeusedtomeasureadenosine
in cerebellar slices.
To test that the inosine arose from the metabolism
of adenosine and that hypoxanthine arose from inosine
breakdown, adenosine and inosine were applied to slices.
Following a 1min application of 100μm adenosine,
3.2±0.7μm inosine and 0.3±0.06μm hypoxanthine
were detected (n=5) and 100μm inosine produced
0.7±0.1μm hypoxanthine (n=5). These results
demonstratethatcerebellarslicescontaintheenzymesthat
rapidlybreakdownadenosinetohypoxanthine(adenosine
deaminase and purine nucleoside phosphorylase). Thus
it is feasible for the inosine/hypoxanthine tone to arise
from the breakdown of endogenous adenosine. The
breakdown of ATP to adenosine suggests that the
extracellular metabolism of ATP could be a potential
source of adenosine.
There was considerable variation in the relative
quantities of the metabolites detected following ATP
application. At the surface of the slice, the proportion
of ATP metabolites (relative proportions of adenosine,
inosine and hypoxanthine) ranged from 25% to 91%
for adenosine, (mean 84±7%), inosine accounted for
0–60% (mean 11±6%) and hypoxanthine accounted for
0–14% (mean 5±1%). Similar results were observed
with biosensors placed within slices. This suggests that
the distribution of metabolising enzymes within slices is
not uniform and that the positioning of the biosensors
relative to the enzymes may dictate the proportions of
metabolites detected. This strengthens the argument that
the inability to detect basal levels of adenosine using
biosensors results from a non-homogenous distribution
of inosine/hypoxanthine in the cerebellum.
Extracellular purine nucleoside phosphorylase (PNP)
is present in the cerebellum
The conversion of inosine to hypoxanthine is catalysed
by purine nucleoside phosphorylase (PNP) which is an
important enzyme in the salvage of nucleotide bases
(Bzowska et al. 2000). Although PNP is considered an
intracellularenzymeithasbeendescribedinratCSF(Silva
et al. 2004). The production of hypoxanthine following
ATP, adenosine or inosine application suggests that an
extracellular form of PNP is expressed in the cerebellum.
To conﬁrm the extracellular expression of PNP, we used
a speciﬁc inhibitor of PNP, immucullinH (Horenstein
& Schramm, 1993). ImmucullinH (200nm) caused a
66±3% reduction in the production of hypoxanthine
(following changing the inﬂow from control saline to
100μm inosine for 2.5min) as measured by a HYPO
biosensor laid on the surface of the slice (n=3, Fig.4A).
ImmucullinH had no effect on the responsiveness of the
HYPO sensor to hypoxanthine, and HYPO sensors could
not detect inosine (Fig.4B)
What determines the extracellular concentration
of adenosine in the cerebellum?
Adenosine kinase. Adenosine kinase is a key intra-
cellular enzyme that phosphorylates adenosine to form
AMP and thus maintains low levels of intracellular
adenosine helping to prevent efﬂux via equilibrative
transporters (for review see Boison, 2006). To
assess whether adenosine kinase is important in the
cerebellum, we blocked the enzyme adenosine kinase
with iodotubercidin and measured the effects on synaptic
transmission and the extracellular concentration of
adenosine. Application of iodotubercidin (1–2μm)
reliably inhibited PF EPSPs (9 out of 10 slices, 51±2%,
Fig.5A) and increased the paired pulse ratio (from
1.58±0.06 to 1.86±0.02) indicating a presynaptic
action. The effects of iodotubercidin were reversed
by 8CPT (1μm) and the mean increase in PF EPSP
amplitude was much larger (168±21%) than in
control (46.1%) indicating increased A1 receptor
Figure 4. Extracellular purine nucleoside phosphorylase (PNP)
metabolises inosine to hypoxanthine in cerebellar slices
A, record from a HYPO biosensor placed on the surface of a cerebellar
slice (the sensor was bent so that it was laid parallel to the slice
surface, increasing the sensitivity of purine detection). Application of
100 μM inosine (bar) produced a large current on the sensor due to
rapid conversion of inosine to hypoxanthine. Application of the PNP
inhibitor, immucillin H (200 nM), markedly reduced the conversion of
inosine to hypoxanthine. Following wash there was recovery in the
conversion of inosine to hypoxanthine. B, the same sensor as A, with
no slice present. The sensor responds to hypoxanthine but does not
respond to inosine.
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Figure 5. Inhibition of adenosine kinase increases the
extracellular concentration of adenosine
A, the adenosine kinase inhibitor iodotubercidin (1 μM) caused a
reduction in PF EPSP amplitude (∼50%) which was reversed by the A1
receptor antagonist 8CPT (1 μM). At the end of the experiment, PF
EPSPs were blocked by kynurenate (5 mM). Graph plots the amplitude
of individual PF EPSPs against time. Inset, iodotubercidin (1 μM) caused
an increase in the paired pulse ratio, conﬁrming presynaptic inhibition
due to adenosine efﬂux. Graph plots the paired pulse ratio against
time for the PF EPSPs in A. The average paired pulse ratio for ﬁve EPSPs
is plotted. B, trace from an ADO and INO sensor placed within the
same slice as A. Application of iodotubercidin (1 μM) produced a
current on the ADO sensor with little effect on the INO sensor. After
calibration there was a net increase in the extracellular adenosine
activation. Iodotubercidin was without effect in only
one slice (although EPSP amplitude was increased by
8CPT, suggesting the presence of an adenosine tone).
Simultaneous biosensor measurements reliably detected
an increased level of purines following iodotubercidin
application (8 out of 10 slices, Fig.5B). After subtraction,
the concentration of adenosine was increased by
0.68±0.1μmandinosinewasincreasedby0.37±0.2μm.
The consistent increase in adenosine suggests that
adenosine kinase is an important and global mechanism
fordeterminingtheextracellularconcentrationofpurines
incerebellarslices.Thisalsodemonstratesthatourmethod
of measuring adenosine is reliable and that the variable
results obtained with other manipulations of adenosine
concentration must be due to biological not technical
mechanisms.
To investigate whether the equilibrative transporters
mediate the increase in adenosine tone following block
of adenosine kinase, we applied NBTI/dipyridamole (to
blockENT1/ENT2)priortoapplicationofiodotubercidin
(to inhibit adenosine kinase). NBTI and dipyridamole
have been used to block ENT1 and ENT2 in a number
of studies (Dunwiddie & Diao, 1994; Frenguelli et al.
2007). In four out of eight slices, the inhibitory actions
of iodotubercidin were almost completely occluded by
the prior application of NBTI/dipyridamole (Fig.5C). At
these synapses the equilibrative transport of adenosine
was abolished and thus the increase in intracellular
adenosine concentration (as a result of adenosine kinase
inhibition) did not result in adenosine efﬂux. In the
remainingfourslices,NBTI/dipyridamoledidnotocclude
the actions of iodotubercidin (Fig.5D). Presumably in
these slices, the equilibrative transport of adenosine
was not effectively blocked and thus the increase in
intracellular adenosine concentration (as a result of
adenosine kinase inhibition) still resulted in an efﬂux
of adenosine. These results suggest heterogeneous
expression of synaptic adenosine transporters with
different proportions of NBTI-/dipyridamole-sensitive
transporters expressed at different synapses.
concentration of ∼0.5 μM. C, the equilibrative transport inhibitors
NBTI (5 μM) and dipyridamole (10 μM) inhibited PF EPSP amplitude and
occluded the effects of iodotubercidin. Although iodotubericidin
(2 μM) had no effect on PF EPSP amplitude (in the presence of
NBTI/dipyridamole), the adenosine receptors were not saturated as
application of adenosine (100 μM) produced increased inhibition. The
modulation of PF EPSPs was reversed by block of A1 receptors (1 μM
8CPT), and EPSPs were blocked by kynurenate (5 mM) at the end of
the experiment. D, NBTI (5 μM) and dipyridamole (10 μM) caused a
small inhibition of PF EPSP amplitude but did not occlude the effects of
iodotubercidin. Application of 2 μM iodotubericidin (in the presence of
NBTI/dipyridamole) markedly inhibited EPSP amplitude. The
modulation of PF EPSPs was reversed by block of A1 receptors (1 μM
8CPT), and EPSPs were blocked by 5 mM kynurenate at the end of the
experiment.
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Equilibrative transporters. We further tested the role
of equilibrative transporters (ENT1 and ENT2) in the
control of the adenosine tone. Adenosine can be removed
from the extracellular space by transport into neurons
and glia. Long applications (30min) of NBTI (5μm)
and dipyridamole (10μm)h a dv a r i a b l ee f f e c t so nP F
EPSP amplitude and biosensor measurements (n=18
slices). Results could be divided into three categories: in
nine slices, PF EPSP amplitude was decreased (47±8%)
with an increase in PPF (from 1.6±0.1 to 1.9±0.1)
and a large increase in EPSP amplitude following 8CPT
(1μm) application (180±20% vs. 46.1±8.6%, Fig.6A),
indicating increased A1 receptor activation. However
there was no shift in the baseline current measured by
purine biosensors, suggesting no change in the bulk
concentration of purines within the slice (Fig.6B). In one
additional slice, as well as reducing PF EPSP amplitude,
the block of adenosine uptake also increased the purine
(inosine/hypoxanthine) concentration measured by the
biosensor (Fig.6C). In the ﬁnal eight slices, blocking
adenosine transport had little or no effect on either
PF EPSP amplitude (decrease 3±6%, PPF 1.56±0.1
vs. 1.5±0.1) or biosensor baseline current. However
applicationof8CPT(1μm)stillincreasedEPSPamplitude
by 55 ±17% (vs. 46.1±8.6% in control) suggesting
that a baseline level of adenosine was present in these
synapses(Fig.6D).Thesehighlyvariabledatadonotreﬂect
technical deﬁciencies of measurement, as iodotubercidin
reliably evokes changes in adenosine tone. Rather
they probably reﬂect that NBTI-/dipyridamole-sensitive
transporters determine the concentration of purines at
only a subset of parallel ﬁbre to Purkinje cell synapses.
Adenosine deaminase. As well as being an intracellular
enzyme, adenosine deaminase can convert extracellular
adenosine to inosine. As our biosensor measurements
routinelydetectanextracellularinosineandhypoxanthine
tone, we have investigated the contribution of adenosine
deaminasetothistonebymeansofsimultaneousbiosensor
and PF EPSP recordings in the presence of EHNA, a
selectiveblockerofadenosinedeaminase(Agarwal,1982).
Although the increase in adenosine concentration
cannot be measured directly (biosensor detection of
adenosineusesadenosinedeaminase),theeffectsofEHNA
can be monitored via changes in PF EPSP amplitude and
bychangesininosine/hypoxanthineconcentration.EHNA
(20μm)iseffectiveatinhibitingadenosinedeaminaseasit
blocks the adenosine deaminase present on the adenosine
biosensor, with no effect on the detection of inosine and
hypoxanthine (Wall & Dale, 2007). Application of EHNA
had only minor effects on PF EPSPs: the mean PF EPSP
amplitude was slightly reduced (11±5%) and the paired
pulse ratio was increased (from 1.4±0.07 to 1.6±0.07,
n=7, Fig.7A and B). Furthermore, application of 1μm
8CPT (in the presence of EHNA) produced a signiﬁcantly
Figure 6. Blocking equilibrative transport has heterogeneous
effects
A, application of ATP (100 μM) caused a reversible inhibition of PF
EPSP amplitude. Block of equilibrative transport with 5 μM NBTI and
10 μM dipyridamole caused a reduction in PF EPSP amplitude, which
was reversed by block of A1 receptors with 8CPT (1 μM). PF EPSPs
were blocked by CNQX at the end of the experiment. Graph plots the
amplitude of individual PF EPSPs against time. Inset, application of ATP
(∗) and NBTI/dipyridamole caused an increase in the paired pulse ratio,
conﬁrming a presynaptic site of action. Graph plots the paired pulse
ratio against time for the PF EPSPs in A. The average paired pulse ratio
for ﬁve EPSPs is plotted. B, trace from an ADO biosensor present in the
same slice as A. Application of 100 μM ATP caused an increase in
adenosine concentration (as a result of metabolism), but 5 μM
NBTI/10 μM dipyridamole had no effect. C, trace from an ADO
biosensor in a different slice. Application of 5 μM NBTI/10 μM
dipyridamole produced a current on the sensor, suggesting an increase
in the concentration of purines in the bulk of the slice. D, application
of ATP (100 μM) caused a reduction in PF EPSP amplitude, but 5 μM
NBTI/10 μM dipyridamole had no effect. There was also no effect on
the paired pulse ratio (not illustrated). There is an adenosine tone, as
block of A1 receptors with 8CPT (1 μM) increased PF EPSP amplitude.
PF EPSPs were blocked by CNQX (10 μM) at the end of the experiment.
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larger increase in PF EPSP amplitude than in control
(84±19% vs. 46.1±8.6%), demonstrating greater A1
receptor activation. Simultaneous biosensor recordings
revealed a fall in the extracellular levels of inosine
Figure 7. The metabolism of adenosine contributes to the
extracellular inosine/hypoxanthine tone but has little effect on
synaptic transmission
A, the adenosine deaminase inhibitor EHNA (20 μM) caused a
reduction in EPSP amplitude (∼17%), which was reversed by block of
A1 receptors with 8CPT (1 μM). EPSPs were blocked at the end of the
experiment with 5 mM kynurenate. Graph plots the amplitude of
individual PF EPSPs against time. B, EHNA caused an increase in the
paired pulse ratio whereas 8CPT reduced the ratio, conﬁrming a
presynaptic site of action. Graph plots the paired pulse ratio against
time for the PF EPSPs in A. The average paired pulse ratio for ﬁve EPSPs
is plotted. C, trace from an INO sensor placed within the same slice as
A. Application of EHNA caused a fall in the concentration of the
adenosine metabolites inosine/hypoxanthine.
and hypoxanthine, which was coincident with the effect
on PF EPSP amplitude (Fig.7C) There was a fall in
hypoxanthine concentration of 1.2±0.7μm (7 out of 7
slices)andafallininosineconcentrationof0.3±0.2μm(4
outof7slices).Asthebasalconcentrationofhypoxanthine
in the slices is 1.8μm, then at least 66% of the hypo-
xanthine arises from the metabolism of adenosine. The
remaining hypoxanthine could arise from other sources
suchasinosinemonophosphate.Althoughecto-adenosine
deaminase does contribute to the inosine/hypoxanthine
tone, it does not appear to be the major regulator of the
adenosine tone.
Endogenous sources of extracellular adenosine
We have recently demonstrated that action potential-
dependent adenosine release occurs in response to short
trains of electrical stimuli in the molecular layer (Wall
& Dale, 2007). If this adenosine were to be metabolised
to inosine/hypoxanthine then it could contribute to the
extracellular purine tone. We therefore stimulated in the
molecular layer and recorded the release of adenosine
(with an ADO sensor) and measured any breakdown of
the released adenosine to hypoxanthine (with a HYPO
sensor). Following stimulation there was a rapid release
of adenosine (as previously described, Wall & Dale, 2007)
measured on the ADO sensor, followed by a much slower
build-up of hypoxanthine detected by the HYPO sensor
(n=6, Fig.8A). If the entire ADO sensor signal was due
to adenosine, then 360±100nm adenosine was released,
whichwasmetabolisedto45±58nmhypoxanthine.Both
the adenosine and hypoxanthine signals were blocked
following addition of TTX to block action potentials
(1μm,n=3).Iftheactionpotential-dependentreleaseof
adenosine occurs spontaneously, then it could contribute
to the inosine/hypoxanthine tone measured in slices.
Blocking action potential adenosine release with TTX
(1μm) produced a small fall (∼15pA) in the baseline
current of the ADO biosensor in three out of ten slices,
suggesting that activity-dependent adenosine is only a
minorcontributortothepurinetoneintheslice.However
in vivo this source of adenosine may be more important,
as there is much greater parallel ﬁbre activity.
We next tested whether release of ATP is the source
of endogenous adenosine (and the inosine/hypoxanthine
tone).Undercontrolconditionswecouldnotmeasureany
extracellular ATP (in or above the slice), suggesting either
that little ATP is released or that it is rapidly metabolised.
We thus inhibited the metabolism of ATP with ARL67156
(100μm), an inhibitor of ecto-ATPase (Crack et al.
1995).FollowingARL67156application,therewasstillno
difference between ATP and null sensors at either room
temperature(n=15)or33–35◦C(n=20).Similarresults
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Figure 8. What is the source of endogenous adenosine?
A, superimposed traces from ADO and HYPO biosensors placed
parallel to the molecular layer surface. Following stimulation (5 V,
20 Hz, 10 s) in the molecular layer, adenosine is released and a
proportion is metabolised to hypoxanthine. The traces are normalised
were found with other ecto-ATPase inhibitors: PPADS
(10–100μm), suramin (100μm), dipyridamole (10μm,
Connolly & Duley, 2000) and Evans Blue (100μm). We
have previously shown that the agents ARL67156 and
Evans Blue are effective inhibitors of ATP breakdown by
cerebellar slices (Wall & Dale, 2007).
An alternative approach to directly observing the
release of ATP is to inhibit the conversion of ATP
to adenosine and thus measure a fall in adenosine
concentration (measured as an increase in PF EPSP
amplitude and by a fall in inosine/hypoxanthine levels).
The ecto-5 -nucelotidase inhibitor α,β-methylene-ADP
was used to reduce the conversion of AMP to adenosine
(effective in the cerebellum, Wall & Dale, 2007). To
increase the likelihood of reducing the conversion of
ATP to adenosine, α,β-methylene-ADP (100μm) was
applied in combination with ARL67156 (100μm). In the
majority of slices (n=8) there was no effect on either
PF EPSP amplitude or biosensor current (Fig.8B and
C). In four slices there was a small reversible decrease
in inosine/hypoxanthine levels, as detected by a fall in
the baseline current measured by biosensors (mean fall
in current 49±35pA, Fig. 8E). In three out of the four
slices this was accompanied by a small increase in PF
EPSP amplitude (mean increase 8.6±5.8%, Fig. 8D).
Upon wash there was a transient increase in adenosine
concentration, presumably as accumulated ADP and
AMP are rapidly broken down to adenosine by the now
uninhibitedenzymes.Thiswasmeasuredbybiosensorsasa
currentincreaseof56±23pAandbyatransientreduction
in PF EPSP amplitude of 36.6±11% (Fig.8D and E). We
therefore ﬁnd that metabolism of ATP may contribute to
the production of adenosine in some slices, but that in
many slices this does not appear to be the source of the
purine tone.
by the biosensor calibration, assuming that all ADO biosensor signal
results from adenosine detection. B, application of
α,β-methylene-ADP (100 μM) and ARL67156 (100 μM), to reduce
conversion of ATP to adenosine, had no effect on PF EPSP amplitude.
However, application of 8CPT (1 μM) increased PF EPSP amplitude,
demonstrating that synaptic A1 receptors were activated by
endogenous adenosine. Graph plots the amplitude of individual PF
EPSPs against time. C, trace from ADO biosensor positioned in the
same slice as A. Application of 100 μM α,β-methylene-ADP and
ARL67156 had no effect on the baseline current. D, application of
α,β-methylene-ADP (100 μM) and ARL67156 (100 μM) increased PF
EPSP amplitude. Upon wash there was a transient reduction in PF EPSP
amplitude below control levels. E, trace from ADO biosensor
positioned in the same slice as D. Addition of α,β-methylene-ADP and
ARL67156 caused a reduction in the baseline current (reduction in the
conversion of ATP to adenosine, coincident with increase in PF EPSP
amplitude). Upon wash there was a transient increase in the level of
adenosine, which coincided with the inhibition of PF EPSP amplitude.
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Discussion
Many studies have demonstrated the presence of an
adenosine tone in the CNS (including the cerebellum,
Takahashi et al. 1995; Dittman & Regehr, 1996). We
have conﬁrmed this by examining synaptic transmission.
Nevertheless, direct measurements with biosensors failed
to reliably detect an extracellular adenosine tone in the
cerebellum. Instead we demonstrated the presence of an
extracellular inosine and hypoxanthine tone that arises
(at least in part) from the breakdown of adenosine.
The conversion of adenosine to hypoxanthine requires
the extracellular expression of adenosine deaminase and
purinenucleosidephosphorylase(PNP).Theinhibitionof
the conversion of inosine to hypoxanthine by the speciﬁc
PNP inhibitior immucullin-H conﬁrms the extracellular
expression of PNP. This is unexpected since PNP is
usuallyconsideredanintracellularenzyme(Bzowskaetal.
2000). Interestingly, astrocytes cultured from neonatal
cerebellum also metabolise exogenous ATP to hypo-
xanthine(Winketal.2003),suggestingthattheadenosine
metabolising enzymes could be expressed by glia. The
rationalefortheconversionofadenosinetoinosineseems
obvious: the conversion of active (adenosine) to inactive
(inosine) molecules. Although inosine is often considered
inert, its metabolism to hypoxanthine suggests that it
may be functionally active and plays some role in the
cerebellum. There is growing support for inosine being
active as it appears to play a role in the immune system
and may be neuroprotective (Hasko et al. 2004).
Inability to directly detect endogenous adenosine
with biosensors
Incommonwithﬁndingsinotherstudies(Takahashietal.
1995; Dittman & Regehr, 1996), parallel ﬁbre–Purkinje
cell synaptic transmission is tonically inhibited by endo-
genous adenosine in cerebellar slices. However we
have been unable to directly measure this extracellular
adenosine using biosensors. A similar ﬁnding has been
reported in the hippocampus where an adenosine tone
was not detectable in three out of four slices, although
tonicadenosine-mediatedsynapticinhibitionwaspresent
(Frenguelli et al. 2007). It is unlikely that the
levels of adenosine are below the levels of detection,
as pharmacological experiments have estimated that
200–400nmadenosineispresentintheextracellularspace
ofthebrain(Dunwiddie&Diao,1994).Thisconcentration
of adenosine would give a current on an ADO biosensor
of60–120pA,whichinnormalconditionswouldeasilybe
detected. There are two possibilities which would explain
this inability to detect adenosine: ﬁrstly, adenosine is
metabolisedtoinosine/hypoxanthinebeforeitreachesthe
sensor. It could be argued that the sensor is further from
the adenosine release sites than the A1 receptors and thus
breakdown in or around the synapses occurs before any
purines reach the biosensor. However the large density
of parallel ﬁbre synapses in the molecular layer makes it
unlikelythatthesensordoesnotsamplefromthesynaptic
compartment. Furthermore, blockade of extracellular
breakdown (with EHNA) had little effect on synaptic
inhibition, suggesting that it is not the major mechanism
of removing adenosine. Dilution of adenosine before
detection was also unlikely, as biosensors were inserted
through the slice and the sensing area of the biosensors
wasinintimatecontactwiththetissue.Secondly,itismore
likely that a non-homogenous distribution of inosine and
hypoxanthine in the extracellular space prevented reliable
measurement of adenosine for technical reasons. If the
levels of inosine/hypoxanthine are not equivalent for each
sensor (ADO, INO and HYPO), then upon subtraction
an inaccurate adenosine concentration will be measured.
A failure of subtraction will result in either an over-
estimateorunderestimateoftheadenosineconcentration.
Subtraction of the calibrated inosine and hypoxanthine
signals gave either a negative adenosine signal or a large
adenosinesignal(1–2μm).Thepresenceofanon-uniform
distribution of inosine and hypoxanthine is supported
by the observations that (1) there is a large variation in
the amount of inosine and hypoxanthine measured in
different slices, and (2) movement of sensors to different
parts of the slice detected differing amounts of inosine
and hypoxanthine following ATP application (M.J. Wall
andN.Dale,unpublishedobservations).Aheterogeneous
distributionofinosine/hypoxanthinecouldstemfromthe
distribution of adenosine-metabolising enzymes. If the
enzymes are clustered (rather than spread uniformly),
then the positioning of the sensors relative to the enzymes
will determine the amounts of inosine and hypoxanthine
detected. Future work is required to test directly for the
clusteringofenzymes.Despitetheselimitationswereliably
observed a purine tone. Furthermore, when we used
iodotubercidin (to block adenosine kinase) there was a
global increase in the adenosine tone, which was reliably
detected by the biosensors.
Control of purine levels in cerebellum compared
to other brain regions
The levels of adenosine in the cerebellum are controlled
by the balance between the rates of production and
elimination. The tone of inosine and hypoxanthine arises
(at least in part) from adenosine metabolism. What is
the source of this adenosine? The two major possibilities
are production via extracellular ATP breakdown (for
review see Zimmermann, 2000) or direct release (either
by transport or by exocytosis). Although we have used
several different methods to distinguish between these
possibilities, the major source of adenosine remains
uncertain. It has not been possible to directly measure
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ATPincerebellarsliceswithbiosensors(limitofdetection
∼60nm),andreducingATPbreakdown(withecto-ATPase
inhibitors) did not reveal an ATP signal. Thus either the
ATP tone described by Brockhaus et al. (2004) (detected
indirectly by its effect on the spontaneous activity of
inhibitory interneurons) must be too small to detect by
our methods, or the breakdown of ATP is very rapid
and not prevented by the inhibitors. However, slowing
the conversion of ATP to adenosine did reduce the
concentration of adenosine metabolites in some slices.
However, the reduction was small (15%) and the effect
on EPSP amplitude was minor (10% increase vs. 46%
inhibition). Thus the contribution of ATP metabolism
to the purine tone appears minor. This contrasts with
the hippocampus, where metabolism of ATP is a major
contributor to the purine tone (Frenguelli et al. 2007;
Pascual et al. 2005).
We have recently described the release of adenosine in
response to focal electrical stimulation of the molecular
layer, a process which is both Ca2+ and TTX sensitive
(Wall & Dale, 2007). Blocking any spontaneous release of
action potential-dependent adenosine release with TTX
had only a small effect on the inosine/hypoxanthine tone.
However, in vivo, the activity of parallel ﬁbres is much
greater and thus this source of adenosine may be much
more important.
Elimination of adenosine occurs by a combination
of two processes: metabolism (by adenosine deaminase)
to inactive metabolites and transport into neurons
and glia followed by phosphorylation to AMP (by
adenosinekinase).Usingpharmacologicalagents,wehave
investigatedwhichofthesecomponentsismoreimportant
in determining extracellular adenosine levels in the
cerebellum. Changes in adenosine levels were assessed by
comparingsynapticinhibitionwithdirectmeasurementof
purinesviabiosensors.Blockingadenosinedeaminasehad
minoreffectsonparallelﬁbre–Purkinjecellsynaptictrans-
mission (∼10% reduction), but did reduce the levels of
extracellularinosineandhypoxanthine(∼50%)measured
by biosensors. The small effect of EHNA on synaptic
transmission suggests that extracellular metabolism is
not the major mechanism controlling synaptic adenosine
concentration, and adenosine deaminase maybe located
outside the synapses. Similar small effects of EHNA
on synaptic transmission in the hippocampus have also
been observed (Dunwiddie & Diao, 1994; Pak et al.
1994). The effect of EHNA on the inosine/hypoxanthine
tone demonstrates that around half of the tone arises
from adenosine metabolism (the rest may arise from
other sources such as inosine monophosphate). As the
tone of inosine/hypoxanthine is ∼1–2μm, the adenosine
concentrationwouldbeexpectedtoincreaseby0.5–1μm,
which should markedly increase synaptic inhibition. The
small effect of EHNA on synaptic transmission suggests
that any increase in adenosine is presumably diminished
by greater equilibrative transport into neurons and glia
around synapses.
Incontrasttotheminoreffectsofblockingmetabolism,
inhibition of adenosine kinase produced a marked
decrease (∼50%) in PF EPSP amplitude in the majority
of slices, accompanied by a simultaneous increase
in adenosine concentration detected by biosensors.
The agreement of biosensor measurements with the
increase in synaptic inhibition suggests that blocking
adenosine kinase produces a global increase in adenosine
concentration. Presumably blockade of adenosine kinase
causes an increase in the intracellular concentration
of adenosine and a resultant efﬂux of adenosine via
equilibrative transporters (see Boison, 2006). The greater
importance of adenosine kinase activity compared to
extracellular adenosine metabolism has been observed in
other brain regions (Zhang et al. 1993; Pak et al. 1994;
Lloyd & Fredholm, 1995).
The role of equilibrative transport in determining
adenosine concentration was assessed by blocking ENT1
and ENT2. In ∼50% of parallel ﬁbre–Purkinje cell
synapses, synaptic transmission was markedly inhibited
(∼45%) as a result of the build-up of adenosine following
the inhibition of adenosine transport. However (apart
from one slice), no increase in adenosine concentration
could be measured by biosensors. The effects of blocking
equilibrative transport were very inconsistent (compared
to blocking adenosine kinase). We can exclude any
technical difﬁculties in measuring an adenosine increase,
as adenosine was reliably detected following adenosine
kinase inhibition. Also, after removing the biosensors
from the tissue there was very little reduction in
sensitivity.Thusthebiosensorsretaintheirabilitytodetect
adenosine throughout the experiment. Furthermore,
similar biosensors could reliably detect an increase in
adenosine in hippocampal slices following application
of NBTI/dipyridamole (Frenguelli et al. 2007). The
most likely explanation is that equilibrative transport
in the cerebellum is not always effectively blocked by
application of NBTI/dipyridamole. This is supported
by the observation that we cannot always occlude
the effects of iodotubercidin by prior application
of NBTI/dipyridamole. Heterogeneous expression of
ENT1 and ENT2 could lead to variation in the
actions of NBTI/dipyridamole. Although rat ENT1 is
effectively blocked by NBTI, rat ENT2 is only weakly
blocked by NBTI and dipyridamole (Baldwin et al.
2004).Thus variable expression of ENT2 at parallel
ﬁbre synapses, could plausibly account for the observed
effects of NBTI/dipyridamole. Alternatively, differential
phosphorylation of ENT1 and or ENT2 at different
synapses could change the proportion of transport
via ENT1 or ENT2 (Stolk et al. 2005). It is also
possible that there is heterogeneous expression of another
transporter (other than ENT1 and ENT2) that is
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insensitive to NBTI/dipyridamole. The variation in effect
of NBTI/dipyridamole between different slices suggests
that any rise in adenosine concentration is localised and
doesnotspreadbetweenallsynapses.Thisissupportedby
the observation that an increase in purine concentration
(following block of equilibrative transport) could only be
measured by biosensors in one slice. Although antibody
staininghasrevealeddiffuseexpressionofthetransporters
in the molecular layer, granule cell layer and Purkinje cell
bodies(Andersonetal.1999a,b),thedensityofENT1and
ENT2 relative to each other and to individual synapses is
currently unclear.
In conclusion, we have demonstrated that a
combination of biosensor measurements and electro-
physiology can be used to determine how the basal
extracellular levels of adenosine are regulated. Using these
methods, we have documented an inosine/hypoxanthine
tone (undetectable by electrophysiology alone) that has a
heterogeneousdistribution(whichwouldnotbeobserved
with either HPLC or microdialysis). The control of
extracellular adenosine concentration in the cerebellum
appears comparable to that in other brain regions where
the activity of adenosine kinase is the major determining
factor. However the variable effects of blocking adenosine
transport (on both synaptic inhibition and biosensor
measurements) suggest that the transporters display
an unexpected non-uniform distribution relative to
synapses.
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